Immunology

“Diabetes in COVID-19 patients may be transitory”

Many COVID-19 patients newly diagnosed with diabetes during hospital admission may in fact have a temporary form of the disease related to the acute stress of the viral infection, it is claimed.

New diagnoses have plummeted in the pandemic

New diagnoses of common chronic conditions have dramatically declined during the COVID-19 pandemic, according to a new study.

"Common cold T cells protect against Covid"

A new study led by Imperial College London researchers provides the first evidence that T cells from common colds could cross-protect against infection with SARS-CoV-2.

mRNA injection to make CAR T cells

An experimental immunotherapy can temporarily reprogramme patients’ immune cells to attack a specific target via a single injection of messenger RNA (mRNA), similar to the mRNA-based COVID-19 vaccines, according to a new study.

The great big biomedical science quiz: 2021 roundup

As we say goodbye to 2021, we finish the year with two rounds of questions to test members’ knowledge on the pandemic and science headlines from the last 12 months. (Scroll to the bottom for a link to the answers.)

The science of nephrotoxicity

Shahid Nazir Muhammad, Academic and Chartered Scientist, and Claire Corps, Research and Clinical Scientist, give an overview of how kidney transplants in paediatrics can survive with immunosuppression therapy.

Under the microscope: Fomitopsis officinalis

This month: Fomitopsis officinalis

Trial campaign to reduce opioids "is effective"

A campaign that urged GPs to “think twice” before putting a patient on opioid medicines is effective in reducing opioid prescribing in primary care, according to a major study.

Jabs and long Covid

Vaccines reduce the odds of SARS-CoV-2 infection, but also long COVID, says Dr Rose Penfold, discussing her new study.

My lab: The immunology laboratory

Medical Laboratory Assistant Muneebah Jasat gives a guided tour of her lab at the Manchester Royal Infirmary.

Test distinguishes SARS-CoV-2

A tablet-sized device has been developed that can detect multiple COVID-19 antibodies and biomarkers simultaneously.

Top